# PASITHEA THERAPEUTICS CORP \*W EXP 08/12/202

PASITHEA THERAPEUTICS CORP *W EXP 08/12/202 is a security (CUSIP 70261F111) tracked across SEC portfolio filings. 8 institutional managers reported $2K on Form 13F as of 2026-03-31.

## Summary

- Issuer: PASITHEA THERAPEUTICS CORP
- Class: \*W EXP 08/12/202
- CUSIP: 70261F111
- 13F holders: 8
- 13F value: $2K
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [ARMISTICE CAPITAL, LLC](https://search.stillhousedata.com/firm/168978) | NEW YORK, NY | $565 | 50,000 |
| [TWO SIGMA SECURITIES, LLC](https://search.stillhousedata.com/firm/148960) | New York, NY | $556 | 55,644 |
| Marex Group plc | London, X0 | $250 | 25,000 |
| OSAIC HOLDINGS, INC. | PHOENIX, AZ | $150 | 15,000 |
| Kepos Capital LP | NEW YORK, NY | $5 | 334,600 |
| Kepos Capital LP | NEW YORK, NY | $4 | 334,600 |
| [CLEAR STREET LLC](https://search.stillhousedata.com/firm/288933) | NEW YORK, NY | $2 | 71 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/70261F111.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.